Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 8/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.38 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.38 |
| ▸ | CDC25B | P30305 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22922196 | 0.75 | F10 (0.66) | F10HSD11B1PTPN1PTPN2CDC25B | |
| SCHEMBL22922186 | 0.75 | F10 (0.66) | F10HSD11B1PTPN1PTPN2CDC25B | |
| SCHEMBL24722287 | 0.75 | ATM (0.44) | F10HSD11B1PTPN1PTPN2CDC25B | |
| SCHEMBL22922195 | 0.73 | HSD11B1 (0.64) | F10HSD11B1PTPN1PTPN2CDC25B | |
| SCHEMBL13401505 | 0.73 | HSD11B1 (0.64) | F10HSD11B1PTPN1PTPN2CDC25B | |
| SCHEMBL22922106 | 0.73 | HSD11B1 (0.64) | F10HSD11B1PTPN1PTPN2CDC25B | |
| SCHEMBL4927657 | 0.73 | PTPN1 (0.38) | F10HSD11B1PTPN1PTPN2CDC25B | |
| SCHEMBL4927656 | 0.73 | PTPN1 (0.38) | F10HSD11B1PTPN1PTPN2CDC25B | |
| SCHEMBL14089632 | 0.72 | HSD11B1 (0.52) | F10HSD11B1PTPN1PTPN2CDC25B | |
| SCHEMBL267552 | 0.70 | PTPN1 (0.65) | F10HSD11B1PTPN1PTPN2CDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220259249-A1 | INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARNT | UNIVERSITÀ DEGLI STUDI DI ROMA "LA SAPIENZA" (IT) | 2022-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220259249-A1 | INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARNT | ARNT, LCAT, GNPAT | F10 2852/4885HSD11B1 366/4885PTPN1 1885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.